|
Market Cap (17-May) $64,879,684 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (5-May) 10,361,283 (0.51%) (303rd) |
|
52w High $0.090 |
52w Low $0.031 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 18 November 2020, 9:29. The announcement is marked as price sensitive, and is 3 page(s) in length and 280.47kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 1.230% short sold according to ASIC data. It was ranked the 166th most shorted stock on the ASX. It remains ranked 303rd as of the latest reported data (05 May 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| ImpediMed Secures First Commercial Heart Failure Sales | 18 November 2020, 9:29 |
| Revised Appendix 3Y | 16 November 2020, 16:20 |
| Change of Director's Interest Notice - Richard Carreon | 16 November 2020, 13:12 |
| Notice under Section 708A(5)(e) of the Corporations Act | 16 November 2020, 13:12 |
You must be logged in to post a reply.
ImpediMed 